Sanofi Signs Strategic Deal for Exclusive US Over-the-Counter Rights to Tamiflu in Flu Care

Originally published on Sanofi.com

Sanofi signed an agreement with Roche for the exclusive over-the-counter (OTC) rights to Tamiflu for the prevention and treatment of influenza or flu in the US. Under the terms of the agreement, Sanofi will be responsible for leading FDA negotiations for the OTC switch and subsequent exclusive marketing, scientific engagement and distribution of Tamiflu OTC in the US. Tamiflu is currently sold in the US by Genentech, a member of the Roche Group, for prescription use.

“This is a strategic and important transaction for us as we strive to continually bring innovations to the market,” says Alan Main, Executive Vice President, Consumer Healthcare, Sanofi.

“The US market is the largest OTC market in the world and a successful switch of Tamiflu to OTC would support our global cough and cold strategy by expanding into flu with a sustainable point of difference in the market. Tamiflu will offer a significant public health benefit once switched by providing increased access to a safe and efficacious treatment for the prevention and treatment of flu. People would be able to either reduce their chances of getting the flu or, at the first signals, appropriately treat as early as possible during the crucial first 48 hours without having to wait for a doctor’s appointment.”

Flu is a condition for which there is no effective OTC anti-viral treatment. Currently, consumers are only able to treat flu symptoms with available OTC products. Early treatment will help prevent the unnecessary spread of the disease. According to the Centers for Disease Control and Prevention (CDC), over 31 million people in the US suffer from the flu in the US each year, but only about 7 million were treated with an effective product like Tamiflu in 2017.

Under the agreement, in addition to leading the FDA negotiations, Sanofi will be responsible for leading the clinical program and funding all studies needed to support the OTC switch in the US in consultation with leading experts in the field. Roche will continue to market Tamiflu in the rest of the world. Sanofi will retain the rights to first negotiations for switch rights in other selected markets.

Latest News

Sha'Carri Richardson

Sprinter Sha’Carri Richardson Officially Becomes Fastest Woman in America

Sha’Carri Richardson is about to become a household name. On June 20, the 21-year-old sprinter from Dallas, Texas ran the 100-meter U.S. Olympic qualifying heat with a time of 10.64 seconds. Richardson’s finish was the sixth-fastest in history for a woman, and the fourth-fastest time ever for an American woman….

voting reform

Senate Republicans Block ‘For the People Act’ Voter Reform Bill and Effectively Preserve Racist Voting Restrictions

Conservative lawmakers from Georgia to Florida to Texas continue to pass highly restrictive and racist election reform laws designed to keep Democrats and people of color from voting, and the Senate appears powerless — at least for now — to stop their Jim Crow-era antics. The latest blow to the…

NYPD officers

Civilian Complaint Board Reports That Up to 39 New York Cops Should Be Disciplined Following George Floyd Protests

Abuse toward public protesters was rampant all over the U.S. during the summer of 2020. And according to a new report from New York City’s Civilian Complaint Review Board (CCRB), the problem appears to have been especially bad in the country’s most populous city, where 39 officers have been accused…

U.S. Senator Sheldon Whitehouse

Rhode Island Progressive Democratic Senator Sheldon Whitehouse Defends His Membership to an Elite All-White Private Beach Club

In a blow to voters and political supporters in Rhode Island, Democratic Senator Sheldon Whitehouse has come under fire for not only belonging to an exclusive all-white private beach club — but also for defending his membership and saying he doesn’t think it’s a problem. According to NBC News, reporters…

Housing and Urban Development Secretary Marcia Fudge

HUD Secretary Marcia Fudge Says Student Loan Debt Is a Major Hurdle for Black Homeownership

Black Americans are saddled with an overwhelming majority of the nation’s $1.7 trillion student debt — and according to Department of Housing and Urban Development (HUD) Secretary Marcia Fudge, that debt is one of the key factors preventing Black Americans from buying and owning their own home. Business Insider’s Ayelet…